Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-986020 in Diffuse Cutaneous Systemic Sclerosis
NCT02588625Phase 2Withdrawn
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2016
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of bms-986020 in systemic sclerosis (SSc), sponsored by Bristol Myers Squibb. Planned start Feb 2016; status: withdrawn.
02
Drugs
bms-986020
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT02588625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02588625.